SHL Telemedicine Ltd. Unsponsored ADR (SHLT)
(Delayed Data from NSDQ)
$2.93 USD
+0.17 (6.16%)
Updated Oct 11, 2024 01:54 PM ET
After-Market: $3.20 +0.27 (9.21%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
SHLT 2.93 +0.17(6.16%)
Will SHLT be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for SHLT based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for SHLT
12 Health Care Stocks Moving In Monday's Pre-Market Session
SHL Telemedicine GAAP EPS of -$0.24 misses by $0.07, revenue of $27.9M misses by $1.1M
SHL Telemedicine to appoint David Arnon as CEO
SHL Telemedicine names new CEO
SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine